By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



Padualaan 8 (postvak 133)

  Utrecht  3584 CH  The Netherlands
Phone: 31-0-30-253-8800 Fax:


Company News
Merus (MRUS) Reports Fiscal Q1 2017 Results 2/14/2017 10:46:37 AM
Merus (MRUS) Announces Date Of Fiscal Q1 2017 Earnings Release 2/10/2017 6:26:46 AM
Incyte (INCY) And Merus (MRUS) Announce Global Strategic Research Collaboration To Discover And Develop Bispecific Antibodies 12/21/2016 12:56:36 PM
Merus (MRUS) Reports Fiscal Q4 And 2016 Results 12/14/2016 9:47:06 AM
Merus (MRUS) Announces Date Of Fiscal 2016 Earnings Release 12/13/2016 8:08:33 AM
Merus (MRUS) Receives Nasdaq Notice Regarding Minimum Bid Price Requirements 11/17/2016 8:06:27 AM
Merus (MRUS) Announces Third Quarter 2016 Financial Results And Corporate Developments 11/7/2016 7:48:09 AM
Merus (MRUS) Strengthens Executive Management Team With The Appointment Of John Crowley As Chief Financial Officer 11/3/2016 7:37:40 AM
Merus (MRUS) Expands Executive Management Team With The Appointment Of L. Andres Sirulnik, MD, Phd, As Chief Medical Officer 10/26/2016 7:56:50 AM
Merus (MRUS) Receives Milestone Payment From Ono Pharma (OPHLY) For Selection Of Bispecific Antibody Candidate For Clinical Development And Extends Partnership With CMC Service Agreement 10/19/2016 7:49:51 AM